this alteration led to a 500-fold reduction in the heparin-dependent acceleration of thrombin-modified antithrombin interactions , as well as a 10-fold decrease in the avidity of the modified protease inhibitor for mucopolysaccharide .
C0019134
heparin
C0017973
mucopolysaccharide